Image3_The feasibility and efficiency for constructing arteriovenous fistula with <2 mm vein—a systematic review and meta-analysis.tif

BackgroundAutogenous arteriovenous fistula (AVF) is an efficient hemodialysis access for patients with end-stage kidney disease (ESKD). The specific threshold of vein diameter still not reached a consensus.MethodWe conducted a comprehensive search in PubMed, Embase, and Web of Science databases for articles which comparing the treatment outcomes of AVF with 2 mm as vein diameter threshold. Fixed and random effect model were used for synthesis of results. Subgroup analysis was designed to assess the risk of bias.ResultEight high-quality articles were included finally. Among a total of 1,075 patients (675 males and 400 females), 227 and 809 patients possessed ConclusionVein diameter less than 2 mm has a negative impact on the functional maturation rate of AVF, while it does not affect the primary and cumulative patency rates (12 months).</p

Table1_The feasibility and efficiency for constructing arteriovenous fistula with <2 mm vein—a systematic review and meta-analysis.docx

BackgroundAutogenous arteriovenous fistula (AVF) is an efficient hemodialysis access for patients with end-stage kidney disease (ESKD). The specific threshold of vein diameter still not reached a consensus.MethodWe conducted a comprehensive search in PubMed, Embase, and Web of Science databases for articles which comparing the treatment outcomes of AVF with 2 mm as vein diameter threshold. Fixed and random effect model were used for synthesis of results. Subgroup analysis was designed to assess the risk of bias.ResultEight high-quality articles were included finally. Among a total of 1,075 patients (675 males and 400 females), 227 and 809 patients possessed ConclusionVein diameter less than 2 mm has a negative impact on the functional maturation rate of AVF, while it does not affect the primary and cumulative patency rates (12 months).</p

Image1_The feasibility and efficiency for constructing arteriovenous fistula with <2 mm vein—a systematic review and meta-analysis.tif

BackgroundAutogenous arteriovenous fistula (AVF) is an efficient hemodialysis access for patients with end-stage kidney disease (ESKD). The specific threshold of vein diameter still not reached a consensus.MethodWe conducted a comprehensive search in PubMed, Embase, and Web of Science databases for articles which comparing the treatment outcomes of AVF with 2 mm as vein diameter threshold. Fixed and random effect model were used for synthesis of results. Subgroup analysis was designed to assess the risk of bias.ResultEight high-quality articles were included finally. Among a total of 1,075 patients (675 males and 400 females), 227 and 809 patients possessed ConclusionVein diameter less than 2 mm has a negative impact on the functional maturation rate of AVF, while it does not affect the primary and cumulative patency rates (12 months).</p

Image2_The feasibility and efficiency for constructing arteriovenous fistula with <2 mm vein—a systematic review and meta-analysis.tif

BackgroundAutogenous arteriovenous fistula (AVF) is an efficient hemodialysis access for patients with end-stage kidney disease (ESKD). The specific threshold of vein diameter still not reached a consensus.MethodWe conducted a comprehensive search in PubMed, Embase, and Web of Science databases for articles which comparing the treatment outcomes of AVF with 2 mm as vein diameter threshold. Fixed and random effect model were used for synthesis of results. Subgroup analysis was designed to assess the risk of bias.ResultEight high-quality articles were included finally. Among a total of 1,075 patients (675 males and 400 females), 227 and 809 patients possessed ConclusionVein diameter less than 2 mm has a negative impact on the functional maturation rate of AVF, while it does not affect the primary and cumulative patency rates (12 months).</p

Adjusted prevalence of indicators of kidney function in the study population.

<p>CKD chronic kidney disease; eGFR estimated glomerular filtration rate; CI confidence intervals.</p

Adjusted factors associated with indicators of kidney damage.

a<p>factors included in multivariate logistic regression were: age(change by 10 years), female, diabetes, hypertension, history of CKD, history of CVD, current smoking, hyperuricemia(>422 µmol/L for men, >363 µmol/L for women), hsCRP(≥1.03 mg/L), HDL ≤0.91 mmol/L, TNF-α ≥1.12 ng/L, IL-1β ≥11.21 ng/L and IL-6≥7.54 ng/L.</p>b<p>factors included in multivariate logistic regression were: age(change by 10 years), female, diabetes, hypertension, hyperlipidemia, history of CKD, BMI (<18.5,18.5–23.9, 24.0–27.9, ≥28.0 kg/m²), hyperuricemia (>422 µmol/L for men, >363 µmol/L for women), cholesterol ≥5.2 mmol/L, triglyceride ≥1.7 mmol/L, LDL ≥4.14 mmol/L, hsCRP (≥1.03 mg/L) and TNF-α ≥1.12 ng/L.</p>c<p>factors included in multivariate logistic regression were: female, education (≥high school vs. d</p><p>factors included in multivariate logistic regression were: age(change by 10 years), female, diabetes, hypertension, history of CKD, history of CVD, current smoking, Hyperuricemia (>422 µmol/L for men, >363 µmol/L for women), cholesterol ≥5.2 mmol/L, triglyceride ≥1.7 mmol/L, LDL ≥4.14 mmol/L, hsCRP(≥1.03 mg/L), TNF-α ≥1.12 ng/L, IL-1β ≥11.21 ng/L and IL-6≥7.54 ng/L.</p><p>OR odds ratio; CI confidence intervals.</p>e<p>Value is median (interquartile range).</p

Characteristics of patients with periodontal disease.

<p>CKD chronic kidney disease; CVD cardiovascular disease; ACR albumin-creatinine ratio; eGFR estimated glomerular filtration rate.</p>a<p>Value is median (interquartile range).</p